Spasticity is defined as “sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex” or from an upper motor neuron lesion (UMN), presenting as an intermittent or sustained involuntary activations of muscles. The region and the extent of impairment depend on the area of the brain or spinal cord that has been damaged. It can occur in the upper and/or lower limbs.
DelveInsight’s “ Spasticity Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Spasticity, historical and forecasted epidemiology as well as the Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Key Highlights from the Spasticity Market Report:
- In the US, about 764,000 children and adults currently have Cerebral Palsy and around 500,000 children under age of 18 currently have Cerebral Palsy.
- In UK the prevalence of CP is 186 per 100,000 population, such that a total of 110,000 people are affected.
- Spasticity affects approximately 35% of those with stroke, more than 90% with CP, about 50% of Traumatic brain injury (TBI) patients, 40% of SCI patients, and between 37% and 78% of MS patients.
- According to DelveInsight’s analysis, Children are affected more with Spasticity as compared to adult.
- United States has the highest percentage of Prevalent diagnosed & treated patients
View Report: https://www.delveinsight.com/report-store/spasticity-market
To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market
Spasticity is the most commonly reported symptom for Multiple sclerosis, seen in 90% of patients. Most cases of spasticity can be subdivided into spinal or cerebral spasticity. Spinal spasticity results from the removal or destruction of supraspinal control and leads to increased excitability of motor neurons, whereas cerebral spasticity stems from a loss of descending inhibition.
The American Association of Neurological Surgeons estimated that spasticity affects more than 12 million people worldwide.
View Report: https://www.delveinsight.com/report-store/spasticity-market
To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market
Some of the Spasticity Companies:
- Osmotica Pharmaceuticals,
- Revance Therapeutics
- Bionorica SE
- Merz Pharmaceuticals
- GW Pharmaceuticals Ltd.
- And Many Others
Spasticity Pipeline Therapies:
- Arbaclofen ER
- DAXI
- BX-1
- And Many Others
View Report: https://www.delveinsight.com/report-store/spasticity-market
To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market
Table of Contents
| 1. | Report Introduction |
| 2. | Executive Summary of Spasticity |
| 3. | Spasticity Market Overview at a Glance |
| 4. | Disease Background and Overview: Spasticity |
| 5. | Case Reports of Spasticity |
| 6. | Spasticity Patient Journey |
| 7. | Spasticity Epidemiology and Patient Population |
| 8. | Epidemiology of Spasticity by Countries (2018–2030) |
| 9. | Spasticity Treatments and Medical Practices |
| 10. | Spasticity Marketed Therapies |
| 11. | Spasticity Emerging Therapies |
| 12. | Spasticity Market Size |
| 13. | 7MM: Country-wise Market Analysis |
| 14. | Spasticity Market Drivers |
| 15. | Spasticity Market Barriers |
| 16. | SWOT Analysis |
| 17. | KOL Views |
| 18. | Reimbursement and market access |
| 19. | Report Methodology |
| 20. | DelveInsight Capabilities |
| 21. | Disclaimer |
| 22. | About DelveInsight |
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.
Spasticity market,Spasticity market trends,Spasticity market forecast,Spasticity market share,Spasticity pipeline,Spasticity treatment algorithm,Spasticity drugs,Spasticity market size,Spasticity CAGR,Spasticity epidemiology